Lixte Biotechnology Holdings, Inc. Profile Avatar - Palmy Investing

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on i…

Biotechnology
US, Pasadena [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
Lixte Biotechnology Holdings, Inc. can't present any analysts estimates at the moment detail analysis.
End of LIXT's Analysis
CIK: 1335105 CUSIP: 539319202 ISIN: US5393193017 LEI: - UEI: -
Secondary Listings
LIXT has no secondary listings inside our databases.